Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Sonablate Corp. raised $200M in funding led by Eleven Ventures to accelerate the global development and commercialization of its AI-powered precision medicine technologies.
Sonablate Corp., based in Charlotte, NC, raised $200M in funding. The company plans to use the funds to support commercialization activities in the MENA region and evaluate manufacturing in Saudi Arabia. Led by CEO Richard Yang, Sonablate focuses on intelligent therapeutic ultrasound technologies. They hold regulatory approvals in over 50 countries worldwide.
Company Information
Company
Sonablate
Location
Charlotte, North Carolina, United States
About
Sonablate Corp. is a provider of AI-powered precision medicine and intelligent, image-guided therapeutic ultrasound technologies. The company is focused on advancing non-invasive treatments across various disease areas, including oncology and women's health. Their innovative platform includes technologies for prostate tissue ablation and neuromodulation, with regulatory approvals in over 50 countries. Led by CEO Richard Yang, Sonablate aims to globalize its commercialization efforts.